{"id":167598,"date":"2023-11-16T15:05:32","date_gmt":"2023-11-16T20:05:32","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/investigating-the-pathogenesis-of-rare-congenital-nerve-disorder-feinberg-news-center\/"},"modified":"2024-08-17T19:07:58","modified_gmt":"2024-08-17T23:07:58","slug":"investigating-the-pathogenesis-of-rare-congenital-nerve-disorder-feinberg-news-center","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/neurology\/investigating-the-pathogenesis-of-rare-congenital-nerve-disorder-feinberg-news-center.php","title":{"rendered":"Investigating the Pathogenesis of Rare Congenital Nerve Disorder &#8230; &#8211; Feinberg News Center"},"content":{"rendered":"<p><p>    A new Northwestern Medicine study has uncovered previously    unidentified intracellular mechanisms in the peripheral nervous    system that cause CharcotMarieTooth Type 2B disease, a rare    congenital disorder that causes sensory deficits and muscle    atrophy and weakness.  <\/p>\n<p>    The findings improve the understanding of the origins of the    disease and may also inform the development of new targeted    therapies, according to the study published    in the Proceedings of the National Academy of    Sciences.  <\/p>\n<p>    These findings are important as they highlight an essential    role for properly regulated mitochondria-lysosome contact site    dynamics and function in the axons of sensory peripheral    neurons, and demonstrate that this may be an important pathway    in the pathogenesis of Charcot-Marie-Tooth Type 2B disease,    said     Yvette Wong, PhD, assistant professor of in the Department    of Neurologys    Division of     Movement Disorders and co-lead author of the study.  <\/p>\n<p>    Charcot-Marie-Tooth Type 2 diseases are a group of hereditary    neuropathic disorders characterized by the degeneration of    axons in peripheral nerves.  <\/p>\n<p>    CharcotMarieTooth Type 2B disease is specifically caused by    mutations in a GTPase protein called Rab7, which leads to the    degeneration of axons of peripheral sensory neurons. Wong and    other Northwestern Medicine investigators previously found that        mitochondria-lysosome contact sites can form to support    essential crosstalk between mitochondria and lysosomes, and    that the untethering of these contact sites is driven by Rab7s    GTPase activity. In the context of CharcotMarieTooth Type 2B    disease, Wong and colleagues also previously discovered that    disease mutant Rab7 prevents the     untethering of these contact sites, resulting in downstream    defects in mitochondrial dynamics.  <\/p>\n<p>    In the current study, Wong and colleagues aimed to determine in    peripheral sensory neurons whether mitochondria-lysosome    contact sites disrupted by mutant Rab7 lead to mitochondrial    defects and whether those defects preferentially occur in axons    in peripheral neurons, as observed in patients with the    disease, or in the neuronal cell body.  <\/p>\n<p>    The investigators created a new mouse model of    Charcot-Marie-Tooth Type 2B disease mutant Rab7; the mice    displayed sensory behavior defects and neuropathy but had    normal motor behavior. Using super-resolution and live    microscopy to study the peripheral sensory neurons from these    mice, the investigators identified mitochondria-lysosome    contact sites that could not efficiently untether in axons.    Importantly, promoting the untethering of mitochondria-lysosome    contact sites was sufficient to improve mitochondrial dynamics    in the axons.  <\/p>\n<p>    The findings suggest that targeted therapies which help improve    mitochondria-lysosome contact site tethering dynamics and    function may improve mitochondrial health in these axons,    according to the authors.  <\/p>\n<p>    These findings also suggest that mitochondria-lysosome contact    sites may play an important role in other genetic forms of    Charcot-Marie-Tooth Type 2 disease, which also exhibit axonal    degeneration, as well as in other neurological disorders that    have mitochondrial dysfunction or axonal degeneration,    according to     Daniela Maria Menichella, MD, PhD, 08, 11 GME, associate    professor of Neurology in the Division of Neuromuscular Disease    and senior author of the study.  <\/p>\n<p>    Our study demonstrates a critical role for    mitochondria-lysosome contact sites to maintain the health of    peripheral nerves. Moreover, defects in this important pathway    have been recently linked to the pathogenesis of multiple    neurodegenerative diseases, including Parkinsons disease and    lysosomal storage disorders, said Menichella, who is also an    associate professor of Pharmacology.  <\/p>\n<p>    According to the authors, next steps include understanding how    defects in mitochondria-lysosome contact site dynamics and    function contribute to the degeneration of peripheral neurons,    uncovering new roles for mitochondria-lysosome contact sites,    and identifying new pathways for how mitochondria and lysosomes    interact with other organelles to maintain neuronal health and    contribute to additional neurological disorders.  <\/p>\n<p>    Together, this work provides important insights into    mitochondria-lysosome contact site regulation in peripheral    neuropathy and has important consequences for advancing the    fields of organelle contact site biology and    neurodegeneration, Menichella said.  <\/p>\n<p>    NirupaDoris Jayaraj, senior research associate in the    Meninchella laboratory, was co-lead author of the study.    Co-authors include Dongjun Ren, a postdoctoral fellow in the    Department of Pharmacology; Tayler Belton, a research    technologist in the Wong laboratory; George Shum, a research    technologist in the Wong lab; Hannah Ball, a student in the    Driskill Graduate Program in Life Sciences (DGP)    program and a member of the Wong lab; and     Dimitri Krainc, MD, chair and the Aaron Montgomery Ward    Professor of Neurology    and director of the     Simpson Querrey Center for Neurogenetics.  <\/p>\n<p>    This work was supported by National Institutes of Health grants    NINDS R00 NS109252, NINDS Diversity Research Supplement    3R00NS109252-04S2, NINDS R24 NS098523 and R37 NS054154, R01    NS104295-0, and NIH HEAL initiative supplement R01 NS104295-01    and R01 AR077691-01.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" href=\"https:\/\/news.feinberg.northwestern.edu\/2023\/11\/15\/investigating-the-pathogenesis-of-rare-congenital-nerve-disorder\" title=\"Investigating the Pathogenesis of Rare Congenital Nerve Disorder ... - Feinberg News Center\" rel=\"noopener\">Investigating the Pathogenesis of Rare Congenital Nerve Disorder ... - Feinberg News Center<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A new Northwestern Medicine study has uncovered previously unidentified intracellular mechanisms in the peripheral nervous system that cause CharcotMarieTooth Type 2B disease, a rare congenital disorder that causes sensory deficits and muscle atrophy and weakness. The findings improve the understanding of the origins of the disease and may also inform the development of new targeted therapies, according to the study published in the Proceedings of the National Academy of Sciences. These findings are important as they highlight an essential role for properly regulated mitochondria-lysosome contact site dynamics and function in the axons of sensory peripheral neurons, and demonstrate that this may be an important pathway in the pathogenesis of Charcot-Marie-Tooth Type 2B disease, said Yvette Wong, PhD, assistant professor of in the Department of Neurologys Division of Movement Disorders and co-lead author of the study.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/neurology\/investigating-the-pathogenesis-of-rare-congenital-nerve-disorder-feinberg-news-center.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246864],"tags":[],"class_list":["post-167598","post","type-post","status-publish","format-standard","hentry","category-neurology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/167598"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=167598"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/167598\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=167598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=167598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=167598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}